aminoglycosides

Preferred Label : aminoglycosides;

MeSH definition : Glycosylated compounds in which there is an amino substituent on the glycoside. Some of them are clinically important ANTIBIOTICS.;

MeSH synonym : Aminoglycoside;

Wikipedia link : https://en.wikipedia.org/wiki/Aminoglycoside;

Is substance : O;

Details

Origin ID

D000617;

UMLS CUI

C0002556;

ATC code(s)
- aminoglycoside antibacterials [ATC Code]
- other aminoglycosides [ATC Code]
Allowable qualifiers
- administration and dosage [MeSH Qualifier]
- adverse effects [MeSH Qualifier]
- agonists [MeSH Qualifier]
- analysis [MeSH Qualifier]
- antagonists and inhibitors [MeSH Qualifier]
- biosynthesis [MeSH Qualifier]
- blood [MeSH Qualifier]
- cerebrospinal fluid [MeSH Qualifier]
- chemical synthesis [MeSH Qualifier]
- chemistry [MeSH Qualifier]
- classification [MeSH Qualifier]
- contraindications [MeSH Qualifier]
- deficiency [MeSH Qualifier]
- economics [MeSH Qualifier]
- genetics [MeSH Qualifier]
- history [MeSH Qualifier]
- immunology [MeSH Qualifier]
- isolation and purification [MeSH Qualifier]
- metabolism [MeSH Qualifier]
- pharmacokinetics [MeSH Qualifier]
- pharmacology [MeSH Qualifier]
- physiology [MeSH Qualifier]
- poisoning [MeSH Qualifier]
- radiation effects [MeSH Qualifier]
- standards [MeSH Qualifier]
- supply and distribution [MeSH Qualifier]
- therapeutic use [MeSH Qualifier]
- toxicity [MeSH Qualifier]
- urine [MeSH Qualifier]
CISMeF manual mappings
- Aminoglycosides adverse reaction (disorder) [SNOMED CT concept]
- Aminoglycosides poisoning (disorder) [SNOMED CT concept]
Currated CISMeF NLP mapping
- Aminoglycoside (substance) [SNOMED CT concept]
- Aminoglycoside Antibiotic [NCIt concept]
- Aminoglycosides [Bloc CIM-11]
- Product containing aminoglycoside (product) [SNOMED CT concept]
- aminoglycoside, nos [SNOMED Notion]
False automatic mappings
- Aminoglycosides [ICD-10 Sub-category (who)]
- Aminoglycosides [ICD-10 Sub-category (who)]
- Poisoning by, adverse effect of and underdosing of aminoglycosides [ICD-10 Sub-category]
Indexing information
- kibdelomycin [MeSH Supplementary Concept]
Record concept(s)
- aminoglycosides [MeSH concept]
Related MeSH Supplementary Concept(s)
- 1,2-diamino-1,2-N,N'-carbonyl-1,2-dideoxyglucose hydrate [MeSH Supplementary Concept]
- 1-((2-hydroxyethyl)amino)-2-amino-1,2-dideoxyglucose triphenyltin(IV) [MeSH Supplementary Concept]
- 1-N-acetylistamycin B [MeSH Supplementary Concept]
- 1-deamino-1-hydroxyxylostasin [MeSH Supplementary Concept]
- 1-deamino-2-deoxy-2 epi-aminofortimycin B [MeSH Supplementary Concept]
- 1-deamino-2-deoxy-2-epi-aminofortimycin A [MeSH Supplementary Concept]
- 1-deamino-2-deoxyfortimicin A [MeSH Supplementary Concept]
- 1-deamino-2-deoxyfortimicin B [MeSH Supplementary Concept]
- 1-epidactimicin [MeSH Supplementary Concept]
- 1-octadecanoyl-2-nonadecanoyl-3-O-(6-amino-6-deoxy)-beta-D-glucopyranosyl-sn-glycerol [MeSH Supplementary Concept]
- 13-hydroxyglucopiericidin A [MeSH Supplementary Concept]
- 2'''-hydroxychlorothricin [MeSH Supplementary Concept]
- 2''-N-acetylistamycin B [MeSH Supplementary Concept]
- 2''-N-formimidoylsporaricin A [MeSH Supplementary Concept]
- 2''-formimidoylistamycin A [MeSH Supplementary Concept]
- 2''-formimidoylistamycin B [MeSH Supplementary Concept]
- 2-O-methanesulfonylfortimycin B [MeSH Supplementary Concept]
- 2-amino-3-O-demethyl-2-deoxyfortimicin A [MeSH Supplementary Concept]
- 2-deoxy-3-demethoxyfortimicin A [MeSH Supplementary Concept]
- 2-deoxy-4-N-glycyl-6-O-(alpha-nebrosaminyl)fortamine [MeSH Supplementary Concept]
- 2-deoxyfortimycin A [MeSH Supplementary Concept]
- 2-deoxyfortimycin B [MeSH Supplementary Concept]
- 20'-deschloro-C-1027 [MeSH Supplementary Concept]
- 3',11-dibutyrylankinomycin [MeSH Supplementary Concept]
- 3'-O-decarbamoylirumamycin [MeSH Supplementary Concept]
- 3'-deoxytalopiericidin A1 [MeSH Supplementary Concept]
- 3'-hydroxydianemycin [MeSH Supplementary Concept]
- 3'-rhamnopiericidin A(1) [MeSH Supplementary Concept]
- 3-O-demethylfortimicin A [MeSH Supplementary Concept]
- 3-O-demethylfortimicin B [MeSH Supplementary Concept]
- 3-O-demethylsporaricin A [MeSH Supplementary Concept]
- 3-amino-3-demethoxyfortimicin A [MeSH Supplementary Concept]
- 3-de-O-methyl-2-deoxy-4-N-glycyl-6-O-(alpha-nebrosaminyl)fortamine [MeSH Supplementary Concept]
- 3-de-O-methylsporaricin A sulfate [MeSH Supplementary Concept]
- 4'-O-demethyldianemycin [MeSH Supplementary Concept]
- 4'-deoxyparomamine [MeSH Supplementary Concept]
- 4-N-(2-aminoethanesulfonyl)fortimicin B [MeSH Supplementary Concept]
- 4-N-(4-aminobenzenesulfonyl)fortimicin B [MeSH Supplementary Concept]
- 4-N-glycyl sannamycin C [MeSH Supplementary Concept]
- 4-N-glycyllysinomicin [MeSH Supplementary Concept]
- 4-O-acetyl-3,6-di-O-benzyl-2-deoxy-2-phthalimido-alpha,beta-glucopyranosyl chloride [MeSH Supplementary Concept]
- 5-(O-(2-O-(6-amino-6-deoxy-beta-idopyranosyl)-beta-ribofuranosyl)-1-N-4-amino-2-hydroxybutanoyl)-3'-deoxyparomamine [MeSH Supplementary Concept]
- 5-(O-(3-O-(6-amino-6-deoxy-beta-idopyranosyl)-beta-ribofuranosyl)-1-N-4-amino-2-hydroxybutanoyl)-3'-deoxyparomamine [MeSH Supplementary Concept]
- 5-O-(5-amino-5-deoxyribofuranosyl)-1N-(4-amino-2-hydroxybutanoyl)paromamine [MeSH Supplementary Concept]
- 5-O-desosaminylplatenolide [MeSH Supplementary Concept]
- 6'-(R)-methyl-paromamine [MeSH Supplementary Concept]
- 6'-N-methylfortimicin A [MeSH Supplementary Concept]
- 6'-N-methylfortimicin B [MeSH Supplementary Concept]
- 6'-di-N-methylfortimicin A [MeSH Supplementary Concept]
- 6'-di-N-methylfortimicin B [MeSH Supplementary Concept]
- 6'-epifortimicin A [MeSH Supplementary Concept]
- 7'-(3-hydroxypropyl)fortimicin A [MeSH Supplementary Concept]
- A 16316-C [MeSH Supplementary Concept]
- A 201A [MeSH Supplementary Concept]
- A 42867 [MeSH Supplementary Concept]
- A-102395 [MeSH Supplementary Concept]
- AB 74 [MeSH Supplementary Concept]
- AC 4437 [MeSH Supplementary Concept]
- AC326-alpha [MeSH Supplementary Concept]
- BE 12406A [MeSH Supplementary Concept]
- BE 12406B [MeSH Supplementary Concept]
- BU-2313 A [MeSH Supplementary Concept]
- BU-2313 B [MeSH Supplementary Concept]
- C 1027 [MeSH Supplementary Concept]
- DC 102 antibiotic [MeSH Supplementary Concept]
- FE 35A [MeSH Supplementary Concept]
- FE 35B [MeSH Supplementary Concept]
- FG08 compound [MeSH Supplementary Concept]
- Hybrimycins [MeSH Supplementary Concept]
- JU2 antibiotic [MeSH Supplementary Concept]
- LL-AM 31 antibiotics [MeSH Supplementary Concept]
- LL-BM 123 [MeSH Supplementary Concept]
- LL-BM 782 [MeSH Supplementary Concept]
- LL-D49194 alpha1 [MeSH Supplementary Concept]
- LL-D49194 beta1 [MeSH Supplementary Concept]
- LL-D49194 beta2 [MeSH Supplementary Concept]
- MM 47761 [MeSH Supplementary Concept]
- MM 49721 [MeSH Supplementary Concept]
- N-acetylelsamicin A [MeSH Supplementary Concept]
- N-acetylglucosamine ribitol teichoic acid [MeSH Supplementary Concept]
- N-formylfortimicin A [MeSH Supplementary Concept]
- NeoC 1027 chromophore I [MeSH Supplementary Concept]
- NeoC 1027 chromophore II [MeSH Supplementary Concept]
- O-rhamnosyl-(1''-4')wedeloside [MeSH Supplementary Concept]
- O-rhamnosyl--(1''-4')-14'-hydroxywedeloside [MeSH Supplementary Concept]
- OP-1118 [MeSH Supplementary Concept]
- P371 A1 [MeSH Supplementary Concept]
- PA 46101 A [MeSH Supplementary Concept]
- PA 46101 B [MeSH Supplementary Concept]
- PF-06647263 [MeSH Supplementary Concept]
- Pentobra [MeSH Supplementary Concept]
- Pyranmycin [MeSH Supplementary Concept]
- RU 25434 [MeSH Supplementary Concept]
- SCH 49088 [MeSH Supplementary Concept]
- SF 2446A1 [MeSH Supplementary Concept]
- SF 2446A2 [MeSH Supplementary Concept]
- SF 2446A3 [MeSH Supplementary Concept]
- SF 2446B1 [MeSH Supplementary Concept]
- SF 2446B2 [MeSH Supplementary Concept]
- TC007 [MeSH Supplementary Concept]
- THRX 651540 [MeSH Supplementary Concept]
- TLC G 565 [MeSH Supplementary Concept]
- WR279396 [MeSH Supplementary Concept]
- X 14847 [MeSH Supplementary Concept]
- XK 41 [MeSH Supplementary Concept]
- YA 56 [MeSH Supplementary Concept]
- afrigilimycin A [MeSH Supplementary Concept]
- aleurodiscal [MeSH Supplementary Concept]
- altromycin A [MeSH Supplementary Concept]
- altromycin B [MeSH Supplementary Concept]
- altromycin C [MeSH Supplementary Concept]
- altromycin D [MeSH Supplementary Concept]
- altromycin E [MeSH Supplementary Concept]
- altromycin F [MeSH Supplementary Concept]
- altromycin G [MeSH Supplementary Concept]
- altromycin H [MeSH Supplementary Concept]
- altromycin I [MeSH Supplementary Concept]
- aminoglycoside 66-40C [MeSH Supplementary Concept]
- aminoglycoside NB84 [MeSH Supplementary Concept]
- ankinomycin [MeSH Supplementary Concept]
- antibiotic 460 [MeSH Supplementary Concept]
- antibiotic AC6H [MeSH Supplementary Concept]
- antibiotic H107 [MeSH Supplementary Concept]
- antibiotic SS 56C [MeSH Supplementary Concept]
- antibiotic X 14952B [MeSH Supplementary Concept]
- antlermicin B [MeSH Supplementary Concept]
- antlermicin C [MeSH Supplementary Concept]
- ardacin [MeSH Supplementary Concept]
- arenimycin [MeSH Supplementary Concept]
- arginomycin [MeSH Supplementary Concept]
- arisostatin A [MeSH Supplementary Concept]
- arisostatin B [MeSH Supplementary Concept]
- atramycin A [MeSH Supplementary Concept]
- atramycin B [MeSH Supplementary Concept]
- azepinomycin 3-ribofuranoside [MeSH Supplementary Concept]
- boholmycin [MeSH Supplementary Concept]
- brasilicardin A [MeSH Supplementary Concept]
- bromorebeccamycin [MeSH Supplementary Concept]
- cajaminose [MeSH Supplementary Concept]
- calicheamicin 1,2,-dimethyl hydrazine dichloride [MeSH Supplementary Concept]
- calicheamicin T [MeSH Supplementary Concept]
- calicheamicin dienone [MeSH Supplementary Concept]
- calicheamicin enediyne [MeSH Supplementary Concept]
- calicheamicin epsilon [MeSH Supplementary Concept]
- calicheamicin gamma(1)I [MeSH Supplementary Concept]
- calicheamicin gamma(1)I aryltetrasaccharide [MeSH Supplementary Concept]
- calicheamicin theta(1)I [MeSH Supplementary Concept]
- calicheamicin thetaII [MeSH Supplementary Concept]
- calicheamicinone [MeSH Supplementary Concept]
- calichearubicin B [MeSH Supplementary Concept]
- calichemicin aryltetrasaccharide [MeSH Supplementary Concept]
- capuramycin [MeSH Supplementary Concept]
- chaetiacandin [MeSH Supplementary Concept]
- chlorothricin [MeSH Supplementary Concept]
- chrysomycin A [MeSH Supplementary Concept]
- chrysomycin B [MeSH Supplementary Concept]
- cinodine [MeSH Supplementary Concept]
- corifungin [MeSH Supplementary Concept]
- coumamidine gamma1 [MeSH Supplementary Concept]
- coumamidine gamma2 [MeSH Supplementary Concept]
- cytosaminomycin A [MeSH Supplementary Concept]
- cytosaminomycin B [MeSH Supplementary Concept]
- cytosaminomycin C [MeSH Supplementary Concept]
- cytosaminomycin D [MeSH Supplementary Concept]
- dactimicin [MeSH Supplementary Concept]
- dapiramicin B [MeSH Supplementary Concept]
- deacetylravidomycin M [MeSH Supplementary Concept]
- deacetylravidomycin N-oxide [MeSH Supplementary Concept]
- dekamycin [MeSH Supplementary Concept]
- demycarosylturimycin H [MeSH Supplementary Concept]
- desacetylravidomycin [MeSH Supplementary Concept]
- dianemycin [MeSH Supplementary Concept]
- elsamicin A [MeSH Supplementary Concept]
- elsamicin B [MeSH Supplementary Concept]
- epoxykidamycin [MeSH Supplementary Concept]
- esperamicin A1 [MeSH Supplementary Concept]
- esperamicin C [MeSH Supplementary Concept]
- esperamicin D [MeSH Supplementary Concept]
- esperamicin P [MeSH Supplementary Concept]
- ethyl 2-amino-2-deoxy-D-glucopyranoside [MeSH Supplementary Concept]
- etimicin [MeSH Supplementary Concept]
- evernimicin [MeSH Supplementary Concept]
- ezomycin [MeSH Supplementary Concept]
- flavumycin A [MeSH Supplementary Concept]
- fortimicin A [MeSH Supplementary Concept]
- fortimicin B [MeSH Supplementary Concept]
- fortimicins [MeSH Supplementary Concept]
- fucothricin [MeSH Supplementary Concept]
- galacardin A [MeSH Supplementary Concept]
- galacardin B [MeSH Supplementary Concept]
- glucolanomycin [MeSH Supplementary Concept]
- glucopiericidin A [MeSH Supplementary Concept]
- glucopiericidin B [MeSH Supplementary Concept]
- glucopiericidinol A1 [MeSH Supplementary Concept]
- glucopiericidinol A2 [MeSH Supplementary Concept]
- glutamycin [MeSH Supplementary Concept]
- glykenin IV [MeSH Supplementary Concept]
- guanidinoneomycin B [MeSH Supplementary Concept]
- hCTMO1-calicheamicin [MeSH Supplementary Concept]
- helvecardin A [MeSH Supplementary Concept]
- helvecardin B [MeSH Supplementary Concept]
- hikizimycin [MeSH Supplementary Concept]
- hlFVII-LDP-AE fusion protein [MeSH Supplementary Concept]
- hu3S193-N-acetyl gamma calicheamicin dimethyl hydrazide [MeSH Supplementary Concept]
- hydroxygentamicin [MeSH Supplementary Concept]
- indolocarbazole derivative R-6 [MeSH Supplementary Concept]
- inosamycins [MeSH Supplementary Concept]
- iprocinodine [MeSH Supplementary Concept]
- istamycins [MeSH Supplementary Concept]
- kasugamycin [MeSH Supplementary Concept]
- kibdelomycin A [MeSH Supplementary Concept]
- kidamycin [MeSH Supplementary Concept]
- kijanimicin [MeSH Supplementary Concept]
- kosinostatin [MeSH Supplementary Concept]
- landomycin A [MeSH Supplementary Concept]
- landomycin D [MeSH Supplementary Concept]
- landomycin E [MeSH Supplementary Concept]
- landomycin F [MeSH Supplementary Concept]
- landomycin G [MeSH Supplementary Concept]
- landomycin H [MeSH Supplementary Concept]
- largomycin [MeSH Supplementary Concept]
- liposidomycin A-(I) [MeSH Supplementary Concept]
- liposidomycin A-(II) [MeSH Supplementary Concept]
- liposidomycin A-(III) [MeSH Supplementary Concept]
- liposidomycin A-(IV) [MeSH Supplementary Concept]
- liposidomycins [MeSH Supplementary Concept]
- lobophorin C [MeSH Supplementary Concept]
- lobophorin D [MeSH Supplementary Concept]
- lysinomicin [MeSH Supplementary Concept]
- megalomicin A [MeSH Supplementary Concept]
- mer WF3010 [MeSH Supplementary Concept]
- methyl-2,4-diamino-2,4-dideoxy-6-O-(2,6-diamino-2,6-dideoxy-alpha-D-glucopyranosyl)-beta-D-glucopyranoside [MeSH Supplementary Concept]
- methyldaunosamine [MeSH Supplementary Concept]
- myomycin [MeSH Supplementary Concept]
- nikkomycin [MeSH Supplementary Concept]
- nikkomycin B(X) [MeSH Supplementary Concept]
- nikkomycin B(Z) [MeSH Supplementary Concept]
- nikkomycin J [MeSH Supplementary Concept]
- nikkomycin S(X) [MeSH Supplementary Concept]
- nikkomycin S(Z) [MeSH Supplementary Concept]
- nikkomycin So(X) [MeSH Supplementary Concept]
- nikkomycin So(Z) [MeSH Supplementary Concept]
- nikkomycin X [MeSH Supplementary Concept]
- nikkomycin pseudo-J [MeSH Supplementary Concept]
- nikkomycin pseudo-Z [MeSH Supplementary Concept]
- oligostatin C [MeSH Supplementary Concept]
- oligostatin D [MeSH Supplementary Concept]
- oligostatin E [MeSH Supplementary Concept]
- oviedomycin [MeSH Supplementary Concept]
- oxyplicacetin [MeSH Supplementary Concept]
- papulacandin B [MeSH Supplementary Concept]
- papulacandins [MeSH Supplementary Concept]
- paromamine [MeSH Supplementary Concept]
- parvulomycin [MeSH Supplementary Concept]
- pavoninin 1 [MeSH Supplementary Concept]
- pavoninin-4 [MeSH Supplementary Concept]
- phenelfamycin A [MeSH Supplementary Concept]
- phenelfamycin B [MeSH Supplementary Concept]
- phenelfamycin C [MeSH Supplementary Concept]
- phenelfamycin E [MeSH Supplementary Concept]
- phenelfamycin F [MeSH Supplementary Concept]
- phenelfamycin G [MeSH Supplementary Concept]
- phenelfamycin H [MeSH Supplementary Concept]
- platenomycin s [MeSH Supplementary Concept]
- pluramycin [MeSH Supplementary Concept]
- propylamycin [MeSH Supplementary Concept]
- pulvomycin [MeSH Supplementary Concept]
- pyrankacin [MeSH Supplementary Concept]
- quinocycline [MeSH Supplementary Concept]
- ravidomycin [MeSH Supplementary Concept]
- rubiflavin [MeSH Supplementary Concept]
- sannamycin A [MeSH Supplementary Concept]
- sannamycin B [MeSH Supplementary Concept]
- sannamycin C [MeSH Supplementary Concept]
- saptomycin B [MeSH Supplementary Concept]
- saptomycin D [MeSH Supplementary Concept]
- saptomycin E [MeSH Supplementary Concept]
- sch 20656 [MeSH Supplementary Concept]
- sch 38516 [MeSH Supplementary Concept]
- sch 38518 [MeSH Supplementary Concept]
- sch 39185 [MeSH Supplementary Concept]
- sibiromycin [MeSH Supplementary Concept]
- sisamine [MeSH Supplementary Concept]
- solfapterin [MeSH Supplementary Concept]
- sorangicin A [MeSH Supplementary Concept]
- sorangicin B [MeSH Supplementary Concept]
- sorbistins [MeSH Supplementary Concept]
- sporaricins [MeSH Supplementary Concept]
- sporaviridin [MeSH Supplementary Concept]
- streptolydigin [MeSH Supplementary Concept]
- streptomycylamine [MeSH Supplementary Concept]
- swalpamycin [MeSH Supplementary Concept]
- telavancin [MeSH Supplementary Concept]
- tetrocarcin A [MeSH Supplementary Concept]
- tetrocarcin B [MeSH Supplementary Concept]
- tetrocarcin C [MeSH Supplementary Concept]
- tetrocarcin E(1) [MeSH Supplementary Concept]
- tetrocarcin E(2) [MeSH Supplementary Concept]
- tetrocarcin F [MeSH Supplementary Concept]
- tetrocarcin F-1 [MeSH Supplementary Concept]
- tetronolide [MeSH Supplementary Concept]
- tirandalydigin [MeSH Supplementary Concept]
- tirandamycin A [MeSH Supplementary Concept]
- tirandamycin B [MeSH Supplementary Concept]
- tirandamycin C [MeSH Supplementary Concept]
- tirandamycin D [MeSH Supplementary Concept]
- toromycin [MeSH Supplementary Concept]
- trioxacarcin [MeSH Supplementary Concept]
- trioxacarcin DC-45-A2 [MeSH Supplementary Concept]
- ts2037 [MeSH Supplementary Concept]
- unphenelfamycin [MeSH Supplementary Concept]
- urdamycin B [MeSH Supplementary Concept]
- urdamycin C [MeSH Supplementary Concept]
- urdamycin D [MeSH Supplementary Concept]
- urdamycin E [MeSH Supplementary Concept]
- urdamycin F [MeSH Supplementary Concept]
- urdamycin H [MeSH Supplementary Concept]
- validamycin H [MeSH Supplementary Concept]
- vancomycin B [MeSH Supplementary Concept]
- verdamicin [MeSH Supplementary Concept]
- vertilmicin [MeSH Supplementary Concept]
- vicenistatin [MeSH Supplementary Concept]
- violamycin BI [MeSH Supplementary Concept]
- violamycins [MeSH Supplementary Concept]
- wassumycin [MeSH Supplementary Concept]
- youlemycin [MeSH Supplementary Concept]
See also
- amino sugars [MeSH Descriptor]
Semantic type(s)
- Organic Chemical [UMLS semantic type]
- Pharmacologic Substance [UMLS semantic type]
UMLS correspondences (same concept)
- Aminoglycoside (substance) [SNOMED CT concept]
- Product containing aminoglycoside (product) [SNOMED CT concept]
- aminoglycoside, nos [SNOMED Notion]
Validated automatic mappings to BTNT
- Substance with aminoglycoside structure and antibacterial mechanism of action (substance) [SNOMED CT concept]

Keyword's position in hierarchy(ies) :

Main resources

You can consult :

recommendations
documents concerning education
documents for patients